| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |